Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
gene editing
life sciences
national blog main
san francisco blog main
3
×
boston
boston blog main
boston top stories
editas medicine
enzyme
national top stories
san francisco top stories
abbvie
agios therapeutics
allergan
alzheimer's disease
base editing
branden moriarty
broad institute
cas13
clinical study
clinical trials
crispr
crispr therapeutics
crispr-cas9
cynthia collins
data
david liu
deals
disease
dna
editor
editr
feng zhang
gag
genome editing
harvard university
hunter syndrome
ids
intellia therapeutics
What
editing
3
×
gene
editas
medicine
therapeutics
abbvie
alliance
beam
benefit
biotech
cas
crispr
editor
exits
experimental
founders
genetic
going
gotten
harvard
humans
isn't
jump
landmark
little
mass
medicines
morning
nasdaq
pact
partnership
phase
precise
pruning
reported
reports
research
results
returning
rights
Language
unset
Current search:
editing
×
biotech
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M